About Index Trending news
Analyze
Pricing
BIND Therapeutics

BIND Therapeutics

Work at BIND Therapeutics? Add yourself to this profile

BIND Therapeutics

BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.
Edit Profile
More info

Elsewhere

Also headquartered in Cambridge

MIT MIT Raspberry Pi Raspberry Pi ARM ARM Xconomy Xconomy HubSpot HubSpot Mobile.co Mobile.co nuTonomy nuTonomy Biogen Biogen Hopper Hopper Sarepta Therapeutics Sarepta Therapeutics

Companies in the same industry

Neurohacker Neurohacker Aspire Bariatrics Aspire Bariatrics Merck Merck Tetraphase Pharmaceuticals Tetraphase Pharmaceuticals Cempra Cempra Disease Diagnostic Group Disease Diagnostic Group Adient Medical, Inc. Adient Medical, Inc. Tricida, Inc. Tricida, Inc. Oculis Oculis Euclises Pharmaceuticals Euclises Pharmaceuticals

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
Add round
13 Feb 2012
$25,500,000
Venture capital (Series D)
RUSNANO
29 Jun 2010
$12,400,000
Venture capital (Series C)
Endeavour Vision, Flagship Ventures, Polaris Partners, +2